Market News & Trends
Zosano Pharma & Asahi Kasei Pharma Enter Agreement for Transdermal Patch for Up to $132.5 Million
Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation (AKP) recently announced they have entered into a long-term strategic collaboration for the development, commercialization, and supply…
10/11/2011
Carticept Medical Receives 510(k) Clearance for Navigator Delivery System Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis,…
Carticept Medical Receives 510(k) Clearance for Navigator Delivery System
Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, recently announced it has received clearance from the FDA…
Intellect Neurosciences & ViroPharma Announce $126.5-Million Global Licensing Agreement
Intellect Neurosciences, Inc. recently announced that it has granted an exclusive license to ViroPharma Incorporated regarding certain of Intellect's licensed patents and patent applications related…
10/4/2011
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H Talon Therapeutics, Inc. recently announced its NDA seeking accelerated approval of Marqibo (vincristine…
Boehringer Ingelheim Expands its Business With Biosimilars
As part of its corporate strategy, Boehringer Ingelheim recently announced it will establish a new separate business for the development and commercialization of its own…
CoreRx Adds Additional Capabilities With New Tablet Press
CoreRx, a leader in early drug contract development, has expanded manufacturing capabilities to include the OYSTAR Manesty FLEXITAB, a fully automated, single station tablet press…
Novozymes to Supply Recombumin for Type 2 Diabetes Drug
Novozymes to Supply Recombumin for Type 2 Diabetes Drug Novozymes Biopharma, part of Novozymes A/S, recently announced it has concluded an exclusive supply agreement with…
Silence Therapeutics Signs siRNA Delivery Collaboration
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, recently announced it has entered into an agreement with one of the world's leading global…
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H
Talon Therapeutics, Inc. recently announced its NDA seeking accelerated approval of Marqibo (vincristine sulfate liposomes injection) has been accepted for filing by the FDA. Marqibo…
UPM Pharmaceuticals to Add Low Humidity, OEB 4 & Specialized Xcelodose Manufacturing Capability
UPM Pharmaceuticals recently announced it will expand its existing manufacturing capacity, including an OEB 4 processing room, a low humidity processing suite, and a unique…
Thermo Fisher Scientific Introduces New Imaging ATR Accessory
Thermo Fisher Scientific Inc., a world leader in serving science, recently announced the launch of a new imaging attenuated total reflectance (ATR) accessory offering enhanced…
Unigene Divests Non-Core Asset & Focuses Resources on High Valuation Drug Development & Peptide Delivery
Unigene Laboratories, Inc. recently announced it has divested its non-core asset, Site Directed Bone Growth (SDBG) by assigning seven patent applications to Kieran Murphy, LLC.…
9/27/2011
Thermo Fisher Scientific Introduces New Imaging ATR Accessory Thermo Fisher Scientific Inc., a world leader in serving science, recently announced the launch of a new…
Ambrx & BMS Announce $24-Million Collaboration for Novel Biologics Programs
Ambrx, Inc. and Bristol-Myers Squibb Company recently announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop, and commercialize biologics…
First Application of Haselmeier's Injection Pen Launched
Haselmeier recently announced that the first application of its Axis-D pen platform has been launched. Commissioned by its client Merck Serono, a division of Merck…
Kythera Biopharmaceuticals Raises $37.4-Million Financing
KYTHERA Biopharmaceuticals, Inc. recently announced the closing of a $37.4-million Series D financing. The round featured significant new investments as well as participation from all…
Loxbridge & Dr. Kary Mullis Announce the Formation of Altermune Technologies
Dr. Kary Mullis, the Nobel Prize-winning inventor of the Polymerase Chain Reaction (PCR), the cornerstone of much of today's DNA science, has entered a new…
Alkermes Launches Corporate Operations in Ireland
Alkermes plc recently announced the establishment of its corporate operations in Ireland, with new headquarters located in Dublin. The company, including its headquarters and operations…
9/20/2011
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices Unilife Corporation recently announced the development of its AutoInfusor portfolio of subcutaneous infusion systems for…
